Ganglioneurocytoma

Last revised by Frank Gaillard on 27 Jul 2022

Citation, DOI, disclosures and article data

Citation:

Gaillard F, Ganglioneurocytoma. Reference article, Radiopaedia.org (Accessed on 07 May 2024) https://doi.org/10.53347/rID-53292

DOI:

https://doi.org/10.53347/rID-53292

Permalink:

https://radiopaedia.org/articles/53292

rID:

53292

Article created:

11 May 2017, Frank Gaillard ◉ ◈

Disclosures:

At the time the article was created Frank Gaillard had no recorded disclosures.

View Frank Gaillard's current disclosures

Last revised:

27 Jul 2022, Frank Gaillard ◉ ◈

Disclosures:

At the time the article was last revised Frank Gaillard had the following disclosures:

Radiopaedia Australia Pty Ltd and Radiopaedia Events Pty Ltd, Director, Founder and CEO (Radiopaedia) (ongoing)
Biogen Australia Pty Ltd, Investigator-Initiated Research Grant for CAD software in multiple sclerosis: finished Oct 2021 (past)

These were assessed during peer review and were determined to not be relevant to the changes that were made.

View Frank Gaillard's current disclosures

Revisions:

1 time, by 1 contributor - see full revision history and disclosures

Systems:

Central Nervous System

Ganglioneurocytomas are rare variants of extraventricular neurocytomas, themselves an uncommon variant of central neurocytomas (intraventricular).

They are recognized in the current (2016) WHO classification of CNS tumors when an extraventricular neurocytoma demonstrates a distinctive and definite ganglion cell ¹.